RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Citius Pharmaceuticals Stock

Citius Pharmaceuticals Equity 2025

Citius Pharmaceuticals Equity

70.08 M USD

Ticker

CTXR

ISIN

US17322U3068

WKN

A2DXS0

In 2025, Citius Pharmaceuticals's equity was 70.08 M USD, a -22.85% increase from the 90.83 M USD equity in the previous year.

Citius Pharmaceuticals Aktienanalyse

What does Citius Pharmaceuticals do?

Citius Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Citius Pharmaceuticals's Equity

Citius Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Citius Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Citius Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Citius Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Citius Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Citius Pharmaceuticals stock

What is the equity of Citius Pharmaceuticals this year?

Citius Pharmaceuticals has equity of 70.08 M USD this year.

What was the equity of Citius Pharmaceuticals compared to the previous year?

The equity of Citius Pharmaceuticals has increased/decreased by -22.85% decreased compared to the previous year.

What impact does a high equity have on investors of Citius Pharmaceuticals?

A high equity is advantageous for investors of Citius Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Citius Pharmaceuticals?

A low equity can be a risk for investors of Citius Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Citius Pharmaceuticals affect the company?

An increase in equity of Citius Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Citius Pharmaceuticals affect the company?

A reduction in equity of Citius Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Citius Pharmaceuticals?

Some factors that can affect the equity of Citius Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Citius Pharmaceuticals so important for investors?

The equity of Citius Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Citius Pharmaceuticals take to change the equity?

To change equity, Citius Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Citius Pharmaceuticals pay?

Over the past 12 months, Citius Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Citius Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Citius Pharmaceuticals?

The current dividend yield of Citius Pharmaceuticals is .

When does Citius Pharmaceuticals pay dividends?

Citius Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Citius Pharmaceuticals?

Citius Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Citius Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Citius Pharmaceuticals located?

Citius Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Citius Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Citius Pharmaceuticals from 7/24/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/24/2025.

When did Citius Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/24/2025.

What was the dividend of Citius Pharmaceuticals in the year 2024?

In the year 2024, Citius Pharmaceuticals distributed 0 USD as dividends.

In which currency does Citius Pharmaceuticals pay out the dividend?

The dividends of Citius Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Citius Pharmaceuticals

Our stock analysis for Citius Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Citius Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.